BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2257932)

  • 1. Subcellular localization of HPA-23 in different rat organs: electron microprobe study.
    Berry JP; Galle P
    Exp Mol Pathol; 1990 Dec; 53(3):255-64. PubMed ID: 2257932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the intracellular localization of a polyoxotungstate (HPA-23) by Raman Laser and X fluorescence spectroscopies.
    Cibert C; Jasmin C
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1424-33. PubMed ID: 7181901
    [No Abstract]   [Full Text] [Related]  

  • 3. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.
    Kimberlin RH; Walker CA
    Arch Virol; 1983; 78(1-2):9-18. PubMed ID: 6686005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate.
    Tsiang H; Atanasiu P; Chermann JC; Jasmin C
    J Gen Virol; 1978 Sep; 40(3):665-8. PubMed ID: 690613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia.
    Larnicol N; Augery Y; Le Bousse-Kerdiles C; Degiorgis V; Chermann JC; Teze A; Jasmin C
    J Gen Virol; 1981 Jul; 55(Pt 1):17-23. PubMed ID: 7299368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ammonium-5-tungsto-2-antimoniate (HPA23) can prevent fox rabies.
    Pepin M; Blancou J
    Arch Virol; 1985; 83(3-4):327-9. PubMed ID: 3970678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of HPA-23 (ammonium-21-tungsto-9-antimoniate) for normal human myeloid progenitor cells (GM-CFU) in vitro.
    Aymard JP; Ferry R; Janot C; Schooneman F; Legras B; May T; Streiff F
    Biomed Pharmacother; 1989; 43(6):451-4. PubMed ID: 2590721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of gadolinium injected as soluble salt in rats: a microanalytical study.
    Hocine N; Berry JP; Jaafoura H; Escaig F; Masse R; Galle P
    Cell Mol Biol (Noisy-le-grand); 1995 Mar; 41(2):271-8. PubMed ID: 7787737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome.
    Moskovitz BL
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1300-3. PubMed ID: 3058016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular localization of cerium. A microanalytical study using an electron microprobe and ionic microanalysis.
    Berry JP; Masse R; Escaig F; Galle P
    Hum Toxicol; 1989 Nov; 8(6):511-20. PubMed ID: 2591995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.
    Burgard M; Sansonetti P; Vittecoq D; Descamps P; Guetard D; Herson S; Rozenbaum W; Rouzioux C
    AIDS; 1989 Oct; 3(10):665-8. PubMed ID: 2480798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular localization of antiviral polyoxometalates in J774 macrophages.
    Ni L; Greenspan P; Gutman R; Kelloes C; Farmer MA; Boudinot FD
    Antiviral Res; 1996 Nov; 32(3):141-8. PubMed ID: 8955509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases.
    Herve M; Sinoussi-Barre F; Chermann JC; Herve G; Jasmin C
    Biochem Biophys Res Commun; 1983 Oct; 116(1):222-9. PubMed ID: 6196027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate.
    Friedrich K; Vieira FA; Porrozzi R; Marchevsky RS; Miekeley N; Grimaldi G; Paumgartten FJ
    J Toxicol Environ Health A; 2012; 75(2):63-75. PubMed ID: 22129235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation.
    Vittecoq D; Woerle R; Barre-Sinoussi F; Chermann JC
    Biomed Pharmacother; 1988; 42(1):35-9. PubMed ID: 2457397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the wheat germ DNA polymerase A activity by the antiviral drug HPA-23.
    Aoyama H; Jucá MB; Castroviejo M; Litvak S
    Plant Mol Biol; 1993 Dec; 23(5):1055-60. PubMed ID: 8260625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of DNA polymerase alpha activity by ammonium 21-tungsto-9-antimoniate (HPA23).
    Ono K; Nakane H; Matsumoto T; Barré-Sinoussi F; Chermann JC
    Nucleic Acids Symp Ser; 1984; (15):169-72. PubMed ID: 6097880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Addition of HPA 23 to cyclosporin in the treatment of thrombopenic purpura in HIV-positive subjects].
    Laporte JP; Meyohas MC; Eliaszewicz M; Najman A; Frottier J; Woehrle R
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):870-2. PubMed ID: 2443894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of zirconium in nodular lymphatic cells after administration of soluble salts. Study by electron microprobe.
    Berry JP; Bertrand F; Galle P
    Toxicology; 1990 May; 62(2):239-46. PubMed ID: 2353361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.